-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Leaders from the Shijiazhuang Municipal Bureau of Statistics visited Shijiazhuang Sihua Pharmaceutical for a research visit.
Category:
Time：2020-05-07
On April 28, Luo Jianfang, deputy researcher at the Shijiazhuang Municipal Bureau of Statistics, and her delegation conducted an on-site investigation into the economic performance of Shijiazhuang Sihua Pharmaceutical Co., Ltd. Wang Chunfa, Deputy General Manager of Shijiazhuang Sihua Pharmaceutical, accompanied the delegation during the visit.
On April 28, Luo Jianfang, deputy researcher at the Shijiazhuang Municipal Bureau of Statistics, and her delegation conducted an on-site investigation into the economic performance of Shijiazhuang Sihua Pharmaceutical Co., Ltd. Wang Chunfa, Deputy General Manager of Shijiazhuang Sihua Pharmaceutical, accompanied the delegation during the visit.
Wang Chunfa briefed the research team on the company’s current production and operational status. The research team expressed its appreciation for Shijiazhuang Fourth Pharmaceutical’s approach of overcoming adverse factors to accelerate the company’s development.
The research team pointed out that, affected by the pandemic, all sectors of the city have been hit to varying degrees. It is crucial to promptly grasp the status of enterprises resuming work and production, providing a scientific basis for organizational decision-making and contributing to the city’s economic recovery. The research team emphasized that effective epidemic prevention and control, as well as timely understanding of the resumption of work and production at enterprises and projects, are both the prerequisite and driving force for ensuring the normal operation of the economy. It is also essential to conduct thorough economic monitoring, early warning, and analysis, re-investigating and re-analyzing any issues and difficulties with phased impacts, and comprehensively and promptly reflecting the overall economic situation. Furthermore, we should make good use of support policies at the national, provincial, and municipal levels, intensify publicity efforts, effectively ensure the implementation of these policies, help enterprises resolve their challenges, and boost economic development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license